Human_Gene_name,Description,References
PAX4,Extended Data Table 1 Most significant single-variant associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
SLC30A8,Extended Data Table 1 Most significant single-variant associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
WFS1,Extended Data Table 1 Most significant single-variant associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
KCNJ11,Extended Data Table 1 Most significant single-variant associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
SLC16A11,Extended Data Table 1 Most significant single-variant associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
SLC16A13,Extended Data Table 1 Most significant single-variant associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
SFI1,Extended Data Table 1 Most significant single-variant associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
ABCC8,Extended Data Table 1 Most significant single-variant associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
MC4R,Extended Data Table 1 Most significant single-variant associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
COBLL1,Extended Data Table 1 Most significant single-variant associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
PISD,Extended Data Table 1 Most significant single-variant associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
PAM,Extended Data Table 1 Most significant single-variant associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
PPIP5K2,Extended Data Table 1 Most significant single-variant associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
RAI1,Extended Data Table 1 Most significant single-variant associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
MAEA,Extended Data Table 1 Most significant single-variant associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
PIK3C2B,Extended Data Table 1 Most significant single-variant associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
WDR13,Extended Data Table 1 Most significant single-variant associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
MDM4,Extended Data Table 1 Most significant single-variant associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
TMCC2,Extended Data Table 1 Most significant single-variant associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
ANKRD36C,Extended Data Table 1 Most significant single-variant associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
SINC3A,Extended Data Table 1 Most significant single-variant associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
ZRANB2,Extended Data Table 1 Most significant single-variant associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
CDC123,Extended Data Table 1 Most significant single-variant associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
TGFB1,Extended Data Table 1 Most significant single-variant associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
SLC26A3,Extended Data Table 1 Most significant single-variant associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
BICD1,Extended Data Table 1 Most significant single-variant associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
RNGTT,Extended Data Table 1 Most significant single-variant associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
SNX9,Extended Data Table 1 Most significant single-variant associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
PRR14L,Extended Data Table 1 Most significant single-variant associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
SCN9A,Extended Data Table 1 Most significant single-variant associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
PTGER3,Extended Data Table 1 Most significant single-variant associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
MC4R,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
PAM,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
SLC30A8,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
IGFBPL1,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
BICD1,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
UBE2NL,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
ING3,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
HNF1A,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
NUMA1,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
MAP3K15,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
PDX1,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
DPH7,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
MGAT4C,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
TMEM216,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
HYAL2,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
MBD3,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
SOCS2,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
SLC16A2,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
PTPRC,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
ANGPTL6,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
STAT4,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
PCBP1,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
MAGEB5,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
ARHGEF7,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
SLC48A1,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
DGKK,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
TDRD5,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
TCEA1,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
RXRG,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
KDM7A,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
C19orf66,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
PDF,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
OR2M4,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
RHBDD2,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
HLCS,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
NT5DC1,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
TMEM161B,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
LRRTM3,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
PRSS54,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
MEST,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
RUVBL2,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
FLCN,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
DHX9,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
TRDN,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
ABCB11,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
MAGEE2,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
ANKS3,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
DHRS13,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
PPP3CA,Extended Data Table 2 Most significant gene-level associations from exome-sequencing analysis,https://doi.org/10.1038/s41586-019-1231-2
TCF7L2,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
SLC30A8,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
INS-IGF2,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
TMEM154,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
GRB14-COBLL1,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
PEPD,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
RBMS1,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
TLE4,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
CDKAL1,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
AP3S2,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
CCDC85A,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
ADAMTS9,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
KCNQ1b,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
PRC1,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
SPRY2,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
C2CD4A-C2CD4B,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
DGKB,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
ZBED3,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
MIR4686,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
CDC123-CAMK1D,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
TLE1,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
CILP2-GATAD2A,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
HHEX/IDE,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
GCK,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
NOTCH2,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
HNF1B (TCF2),Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
WFS1,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
GCKR,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
FTO,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
KLHDC5,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
HMGA2b,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
JAZF1,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
BCL2,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
UBE2E2,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
THADA,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
HNF1A,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
LEP- MIR129 ,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
TP53INP1,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
PSMD6,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
RASGRP1,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
ARL15,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
ADCY5,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
DNER,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
FAF1,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
CCND2,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
CENPW,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
LPP,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
TOMM40-APOE,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
KCNQ1b,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
KLF14,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
ATP8B2,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
KCNJ11,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
MTMR3 (ASCC2),Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
ZMIZ1,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
TSPAN8-LGR5,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
IRS1,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
BCAR1,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
INAFM2,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
SRR,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
DMRTA1,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
CDKN2A/B,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
DUSP8,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
POU5F1-TCF19,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
ZFAND3,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
HNF4A- FITM2- R3HDML,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
MPHOSPH9,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
HLA-B,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
PAX4-ARF5-SND1,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
PTPRD,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
VPS26A,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
HNF4A,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
MC4R,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
IGF2BP2,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
ASB3,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
GRK5,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
ST6GAL1,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
GIPR,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
BCL11A,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
GLIS3,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
MAEA,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
PROX1,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
KCNK16,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
ZFAND6,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
GPSM1,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
ANK1,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
SSR1-RREB1,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
MACF1,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
SLC16A13,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
LAMA1,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
CENTD2-ARAP1,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
CDKN2A-B,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
TBC1D4,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
TMEM163,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
PPARG,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
MTNR1B,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
ANKRD55,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
HMG20A,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
PAM,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
CCND2,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
HNF1A,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
FAM60A,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
DUSP9,Table 2 : Direct and local detection of established loci,https://doi.org/10.1007/s00125-019-4880-7
DOCK7,Table S4 : Coloc with GWAS and eQTL,
ATG4C,Table S4 : Coloc with GWAS and eQTL,
L1TD1,Table S4 : Coloc with GWAS and eQTL,
PTGFRN,Table S4 : Coloc with GWAS and eQTL,
CD101,Table S4 : Coloc with GWAS and eQTL,
PTGFRN,Table S4 : Coloc with GWAS and eQTL,
PTGFRN,Table S4 : Coloc with GWAS and eQTL,
CD101,Table S4 : Coloc with GWAS and eQTL,
CD101,Table S4 : Coloc with GWAS and eQTL,
PLEKHO1,Table S4 : Coloc with GWAS and eQTL,
RP11-54A4.2,Table S4 : Coloc with GWAS and eQTL,
PROX1-AS1,Table S4 : Coloc with GWAS and eQTL,
PROX1-AS1,Table S4 : Coloc with GWAS and eQTL,
PROX1-AS1,Table S4 : Coloc with GWAS and eQTL,
URB2,Table S4 : Coloc with GWAS and eQTL,
RNF187,Table S4 : Coloc with GWAS and eQTL,
HMGN2P19,Table S4 : Coloc with GWAS and eQTL,
HMGN2P19,Table S4 : Coloc with GWAS and eQTL,
HMGN2P19,Table S4 : Coloc with GWAS and eQTL,
HMGN2P19,Table S4 : Coloc with GWAS and eQTL,
CCSAP,Table S4 : Coloc with GWAS and eQTL,
HMGN2P19,Table S4 : Coloc with GWAS and eQTL,
HMGN2P19,Table S4 : Coloc with GWAS and eQTL,
HMGN2P19,Table S4 : Coloc with GWAS and eQTL,
HMGN2P19,Table S4 : Coloc with GWAS and eQTL,
HMGN2P19,Table S4 : Coloc with GWAS and eQTL,
HMGN2P19,Table S4 : Coloc with GWAS and eQTL,
HMGN2P19,Table S4 : Coloc with GWAS and eQTL,
HMGN2P19,Table S4 : Coloc with GWAS and eQTL,
HMGN2P19,Table S4 : Coloc with GWAS and eQTL,
HMGN2P19,Table S4 : Coloc with GWAS and eQTL,
HMGN2P19,Table S4 : Coloc with GWAS and eQTL,
RP4-613A2.1,Table S4 : Coloc with GWAS and eQTL,
NUP133,Table S4 : Coloc with GWAS and eQTL,
HMGN2P19,Table S4 : Coloc with GWAS and eQTL,
MYCN,Table S4 : Coloc with GWAS and eQTL,
NRBP1,Table S4 : Coloc with GWAS and eQTL,
FNDC4,Table S4 : Coloc with GWAS and eQTL,
PREB,Table S4 : Coloc with GWAS and eQTL,
ATRAID,Table S4 : Coloc with GWAS and eQTL,
ZNF513,Table S4 : Coloc with GWAS and eQTL,
RBKS,Table S4 : Coloc with GWAS and eQTL,
C2orf16,Table S4 : Coloc with GWAS and eQTL,
AC074117.10,Table S4 : Coloc with GWAS and eQTL,
NRBP1,Table S4 : Coloc with GWAS and eQTL,
KRTCAP3,Table S4 : Coloc with GWAS and eQTL,
NRBP1,Table S4 : Coloc with GWAS and eQTL,
AC074117.10,Table S4 : Coloc with GWAS and eQTL,
AC074117.10,Table S4 : Coloc with GWAS and eQTL,
NRBP1,Table S4 : Coloc with GWAS and eQTL,
ATRAID,Table S4 : Coloc with GWAS and eQTL,
AC074117.10,Table S4 : Coloc with GWAS and eQTL,
NRBP1,Table S4 : Coloc with GWAS and eQTL,
SNX17,Table S4 : Coloc with GWAS and eQTL,
PPM1G,Table S4 : Coloc with GWAS and eQTL,
KRTCAP3,Table S4 : Coloc with GWAS and eQTL,
NRBP1,Table S4 : Coloc with GWAS and eQTL,
NRBP1,Table S4 : Coloc with GWAS and eQTL,
NRBP1,Table S4 : Coloc with GWAS and eQTL,
NRBP1,Table S4 : Coloc with GWAS and eQTL,
GCKR,Table S4 : Coloc with GWAS and eQTL,
FNDC4,Table S4 : Coloc with GWAS and eQTL,
NRBP1,Table S4 : Coloc with GWAS and eQTL,
INHBB,Table S4 : Coloc with GWAS and eQTL,
INHBB,Table S4 : Coloc with GWAS and eQTL,
WNT6,Table S4 : Coloc with GWAS and eQTL,
WNT6,Table S4 : Coloc with GWAS and eQTL,
WNT6,Table S4 : Coloc with GWAS and eQTL,
WNT6,Table S4 : Coloc with GWAS and eQTL,
WNT6,Table S4 : Coloc with GWAS and eQTL,
WNT6,Table S4 : Coloc with GWAS and eQTL,
SEMA3F,Table S4 : Coloc with GWAS and eQTL,
RBM5,Table S4 : Coloc with GWAS and eQTL,
CACNA2D2,Table S4 : Coloc with GWAS and eQTL,
RASSF1,Table S4 : Coloc with GWAS and eQTL,
DOCK3,Table S4 : Coloc with GWAS and eQTL,
CYB561D2,Table S4 : Coloc with GWAS and eQTL,
CISH,Table S4 : Coloc with GWAS and eQTL,
NICN1,Table S4 : Coloc with GWAS and eQTL,
BSN,Table S4 : Coloc with GWAS and eQTL,
MST1,Table S4 : Coloc with GWAS and eQTL,
HYAL3,Table S4 : Coloc with GWAS and eQTL,
GPX1,Table S4 : Coloc with GWAS and eQTL,
HYAL3,Table S4 : Coloc with GWAS and eQTL,
HYAL3,Table S4 : Coloc with GWAS and eQTL,
HYAL3,Table S4 : Coloc with GWAS and eQTL,
HYAL3,Table S4 : Coloc with GWAS and eQTL,
HYAL3,Table S4 : Coloc with GWAS and eQTL,
HYAL3,Table S4 : Coloc with GWAS and eQTL,
HYAL3,Table S4 : Coloc with GWAS and eQTL,
HYAL3,Table S4 : Coloc with GWAS and eQTL,
HYAL3,Table S4 : Coloc with GWAS and eQTL,
HYAL3,Table S4 : Coloc with GWAS and eQTL,
HYAL3,Table S4 : Coloc with GWAS and eQTL,
HYAL3,Table S4 : Coloc with GWAS and eQTL,
HYAL3,Table S4 : Coloc with GWAS and eQTL,
HYAL3,Table S4 : Coloc with GWAS and eQTL,
HYAL3,Table S4 : Coloc with GWAS and eQTL,
MON1A,Table S4 : Coloc with GWAS and eQTL,
ACTR8,Table S4 : Coloc with GWAS and eQTL,
WNT5A-AS1,Table S4 : Coloc with GWAS and eQTL,
LINC00870,Table S4 : Coloc with GWAS and eQTL,
SEMA5B,Table S4 : Coloc with GWAS and eQTL,
ADCY5,Table S4 : Coloc with GWAS and eQTL,
PARP14,Table S4 : Coloc with GWAS and eQTL,
PTPLB,Table S4 : Coloc with GWAS and eQTL,
ADCY5,Table S4 : Coloc with GWAS and eQTL,
IGF2BP2,Table S4 : Coloc with GWAS and eQTL,
MAP3K13,Table S4 : Coloc with GWAS and eQTL,
C3orf65,Table S4 : Coloc with GWAS and eQTL,
C3orf70,Table S4 : Coloc with GWAS and eQTL,
RP11-573D15.8,Table S4 : Coloc with GWAS and eQTL,
RP11-573D15.9,Table S4 : Coloc with GWAS and eQTL,
ST6GAL1,Table S4 : Coloc with GWAS and eQTL,
RP11-573D15.8,Table S4 : Coloc with GWAS and eQTL,
ETV5,Table S4 : Coloc with GWAS and eQTL,
ST6GAL1,Table S4 : Coloc with GWAS and eQTL,
FGFR3,Table S4 : Coloc with GWAS and eQTL,
FGFRL1,Table S4 : Coloc with GWAS and eQTL,
SPON2,Table S4 : Coloc with GWAS and eQTL,
TMEM129,Table S4 : Coloc with GWAS and eQTL,
TMEM129,Table S4 : Coloc with GWAS and eQTL,
TMEM129,Table S4 : Coloc with GWAS and eQTL,
TMEM129,Table S4 : Coloc with GWAS and eQTL,
AC016773.1,Table S4 : Coloc with GWAS and eQTL,
MXD4,Table S4 : Coloc with GWAS and eQTL,
TNIP2,Table S4 : Coloc with GWAS and eQTL,
MSANTD1,Table S4 : Coloc with GWAS and eQTL,
RP11-503N18.5,Table S4 : Coloc with GWAS and eQTL,
FAM86EP,Table S4 : Coloc with GWAS and eQTL,
APOBEC2,Table S4 : Coloc with GWAS and eQTL,
CUL7,Table S4 : Coloc with GWAS and eQTL,
HSP90AB1,Table S4 : Coloc with GWAS and eQTL,
PPP2R5D,Table S4 : Coloc with GWAS and eQTL,
PTK7,Table S4 : Coloc with GWAS and eQTL,
CUL9,Table S4 : Coloc with GWAS and eQTL,
RRP36,Table S4 : Coloc with GWAS and eQTL,
PEX6,Table S4 : Coloc with GWAS and eQTL,
TTBK1,Table S4 : Coloc with GWAS and eQTL,
GTPBP2,Table S4 : Coloc with GWAS and eQTL,
DGKB,Table S4 : Coloc with GWAS and eQTL,
DGKB,Table S4 : Coloc with GWAS and eQTL,
PLEKHA8,Table S4 : Coloc with GWAS and eQTL,
AC005154.8,Table S4 : Coloc with GWAS and eQTL,
BLVRA,Table S4 : Coloc with GWAS and eQTL,
POLD2,Table S4 : Coloc with GWAS and eQTL,
TMED4,Table S4 : Coloc with GWAS and eQTL,
AC004985.12,Table S4 : Coloc with GWAS and eQTL,
PPIA,Table S4 : Coloc with GWAS and eQTL,
GCK,Table S4 : Coloc with GWAS and eQTL,
SFRP1,Table S4 : Coloc with GWAS and eQTL,
GINS4,Table S4 : Coloc with GWAS and eQTL,
NKX6-3,Table S4 : Coloc with GWAS and eQTL,
ANK1,Table S4 : Coloc with GWAS and eQTL,
ANK1,Table S4 : Coloc with GWAS and eQTL,
ANK1,Table S4 : Coloc with GWAS and eQTL,
JAK2,Table S4 : Coloc with GWAS and eQTL,
CDC37L1,Table S4 : Coloc with GWAS and eQTL,
IGHEP2,Table S4 : Coloc with GWAS and eQTL,
RPS6,Table S4 : Coloc with GWAS and eQTL,
BAG1,Table S4 : Coloc with GWAS and eQTL,
ENHO,Table S4 : Coloc with GWAS and eQTL,
C9orf131,Table S4 : Coloc with GWAS and eQTL,
SERPINH1P1,Table S4 : Coloc with GWAS and eQTL,
RP11-195F19.9,Table S4 : Coloc with GWAS and eQTL,
UBE2R2,Table S4 : Coloc with GWAS and eQTL,
KIF24,Table S4 : Coloc with GWAS and eQTL,
UBAP2,Table S4 : Coloc with GWAS and eQTL,
NUDT2,Table S4 : Coloc with GWAS and eQTL,
TLE1,Table S4 : Coloc with GWAS and eQTL,
RP11-154D17.1,Table S4 : Coloc with GWAS and eQTL,
CAMK1D,Table S4 : Coloc with GWAS and eQTL,
PROSER2-AS1,Table S4 : Coloc with GWAS and eQTL,
CAMK1D,Table S4 : Coloc with GWAS and eQTL,
CAMK1D,Table S4 : Coloc with GWAS and eQTL,
CAMK1D,Table S4 : Coloc with GWAS and eQTL,
CAMK1D,Table S4 : Coloc with GWAS and eQTL,
AIFM2,Table S4 : Coloc with GWAS and eQTL,
TSPAN15,Table S4 : Coloc with GWAS and eQTL,
H2AFY2,Table S4 : Coloc with GWAS and eQTL,
SUPV3L1,Table S4 : Coloc with GWAS and eQTL,
HKDC1,Table S4 : Coloc with GWAS and eQTL,
DDX21,Table S4 : Coloc with GWAS and eQTL,
AC022532.1,Table S4 : Coloc with GWAS and eQTL,
KIAA1279,Table S4 : Coloc with GWAS and eQTL,
DCLRE1A,Table S4 : Coloc with GWAS and eQTL,
RP11-57H14.2,Table S4 : Coloc with GWAS and eQTL,
RP11-57H14.2,Table S4 : Coloc with GWAS and eQTL,
RP11-57H14.4,Table S4 : Coloc with GWAS and eQTL,
RP11-324O2.6,Table S4 : Coloc with GWAS and eQTL,
RP11-572P18.1,Table S4 : Coloc with GWAS and eQTL,
C11orf21,Table S4 : Coloc with GWAS and eQTL,
MRPL23-AS1,Table S4 : Coloc with GWAS and eQTL,
TSSC4,Table S4 : Coloc with GWAS and eQTL,
C11orf21,Table S4 : Coloc with GWAS and eQTL,
SYT8,Table S4 : Coloc with GWAS and eQTL,
ART5,Table S4 : Coloc with GWAS and eQTL,
AC129929.5,Table S4 : Coloc with GWAS and eQTL,
RP5-1173A5.1,Table S4 : Coloc with GWAS and eQTL,
C11orf21,Table S4 : Coloc with GWAS and eQTL,
CDKN1C,Table S4 : Coloc with GWAS and eQTL,
AC129929.5,Table S4 : Coloc with GWAS and eQTL,
AC090587.2,Table S4 : Coloc with GWAS and eQTL,
RP5-1173A5.1,Table S4 : Coloc with GWAS and eQTL,
SLC22A18AS,Table S4 : Coloc with GWAS and eQTL,
EIF3M,Table S4 : Coloc with GWAS and eQTL,
EIF3M,Table S4 : Coloc with GWAS and eQTL,
MTNR1B,Table S4 : Coloc with GWAS and eQTL,
SMCO4,Table S4 : Coloc with GWAS and eQTL,
MIR1304,Table S4 : Coloc with GWAS and eQTL,
HIN1L,Table S4 : Coloc with GWAS and eQTL,
NDUFA9,Table S4 : Coloc with GWAS and eQTL,
C12orf5,Table S4 : Coloc with GWAS and eQTL,
CCND2,Table S4 : Coloc with GWAS and eQTL,
DYRK4,Table S4 : Coloc with GWAS and eQTL,
C12orf5,Table S4 : Coloc with GWAS and eQTL,
PRMT8,Table S4 : Coloc with GWAS and eQTL,
PARP11,Table S4 : Coloc with GWAS and eQTL,
AKAP3,Table S4 : Coloc with GWAS and eQTL,
KCNA1,Table S4 : Coloc with GWAS and eQTL,
GALNT8,Table S4 : Coloc with GWAS and eQTL,
EFCAB4B,Table S4 : Coloc with GWAS and eQTL,
RP11-264F23.4,Table S4 : Coloc with GWAS and eQTL,
RP11-320N7.2,Table S4 : Coloc with GWAS and eQTL,
KCNA1,Table S4 : Coloc with GWAS and eQTL,
NDUFA9,Table S4 : Coloc with GWAS and eQTL,
KCNA6,Table S4 : Coloc with GWAS and eQTL,
RP3-377H17.2,Table S4 : Coloc with GWAS and eQTL,
CCND2,Table S4 : Coloc with GWAS and eQTL,
CCND2,Table S4 : Coloc with GWAS and eQTL,
CCND2,Table S4 : Coloc with GWAS and eQTL,
RP11-264F23.4,Table S4 : Coloc with GWAS and eQTL,
RP11-264F23.3,Table S4 : Coloc with GWAS and eQTL,
CCND2,Table S4 : Coloc with GWAS and eQTL,
RP11-264F23.4,Table S4 : Coloc with GWAS and eQTL,
RP11-264F23.3,Table S4 : Coloc with GWAS and eQTL,
CCND2,Table S4 : Coloc with GWAS and eQTL,
CCND2,Table S4 : Coloc with GWAS and eQTL,
RP11-264F23.3,Table S4 : Coloc with GWAS and eQTL,
CCND2,Table S4 : Coloc with GWAS and eQTL,
CCND2,Table S4 : Coloc with GWAS and eQTL,
CCND2,Table S4 : Coloc with GWAS and eQTL,
CCND2,Table S4 : Coloc with GWAS and eQTL,
CCND2,Table S4 : Coloc with GWAS and eQTL,
GPRC5D,Table S4 : Coloc with GWAS and eQTL,
DDX47,Table S4 : Coloc with GWAS and eQTL,
RP11-13G14.4,Table S4 : Coloc with GWAS and eQTL,
FAM124A,Table S4 : Coloc with GWAS and eQTL,
RPS4XP16,Table S4 : Coloc with GWAS and eQTL,
INTS6-AS1,Table S4 : Coloc with GWAS and eQTL,
SERPINE3,Table S4 : Coloc with GWAS and eQTL,
SPRED1,Table S4 : Coloc with GWAS and eQTL,
ZNF200,Table S4 : Coloc with GWAS and eQTL,
CLUAP1,Table S4 : Coloc with GWAS and eQTL,
PDPK1,Table S4 : Coloc with GWAS and eQTL,
CCDC64B,Table S4 : Coloc with GWAS and eQTL,
CLDN6,Table S4 : Coloc with GWAS and eQTL,
RP11-473M20.5,Table S4 : Coloc with GWAS and eQTL,
PAM16,Table S4 : Coloc with GWAS and eQTL,
MTRNR2L4,Table S4 : Coloc with GWAS and eQTL,
RP11-462G12.1,Table S4 : Coloc with GWAS and eQTL,
RP11-95P2.1,Table S4 : Coloc with GWAS and eQTL,
LA16c-380H5.5,Table S4 : Coloc with GWAS and eQTL,
CLUAP1,Table S4 : Coloc with GWAS and eQTL,
TRAP1,Table S4 : Coloc with GWAS and eQTL,
CLUAP1,Table S4 : Coloc with GWAS and eQTL,
NLRC3,Table S4 : Coloc with GWAS and eQTL,
NLRC3,Table S4 : Coloc with GWAS and eQTL,
NAA60,Table S4 : Coloc with GWAS and eQTL,
NLRC3,Table S4 : Coloc with GWAS and eQTL,
CLUAP1,Table S4 : Coloc with GWAS and eQTL,
NLRC3,Table S4 : Coloc with GWAS and eQTL,
CLUAP1,Table S4 : Coloc with GWAS and eQTL,
NLRC3,Table S4 : Coloc with GWAS and eQTL,
CLUAP1,Table S4 : Coloc with GWAS and eQTL,
NLRC3,Table S4 : Coloc with GWAS and eQTL,
NLRC3,Table S4 : Coloc with GWAS and eQTL,
SLX4,Table S4 : Coloc with GWAS and eQTL,
CLUAP1,Table S4 : Coloc with GWAS and eQTL,
NLRC3,Table S4 : Coloc with GWAS and eQTL,
CLUAP1,Table S4 : Coloc with GWAS and eQTL,
CLUAP1,Table S4 : Coloc with GWAS and eQTL,
CLUAP1,Table S4 : Coloc with GWAS and eQTL,
NLRC3,Table S4 : Coloc with GWAS and eQTL,
CLUAP1,Table S4 : Coloc with GWAS and eQTL,
NLRC3,Table S4 : Coloc with GWAS and eQTL,
CLUAP1,Table S4 : Coloc with GWAS and eQTL,
CLUAP1,Table S4 : Coloc with GWAS and eQTL,
CLUAP1,Table S4 : Coloc with GWAS and eQTL,
NLRC3,Table S4 : Coloc with GWAS and eQTL,
NLRC3,Table S4 : Coloc with GWAS and eQTL,
NLRC3,Table S4 : Coloc with GWAS and eQTL,
NLRC3,Table S4 : Coloc with GWAS and eQTL,
CLUAP1,Table S4 : Coloc with GWAS and eQTL,
NLRC3,Table S4 : Coloc with GWAS and eQTL,
CLUAP1,Table S4 : Coloc with GWAS and eQTL,
NLRC3,Table S4 : Coloc with GWAS and eQTL,
CLUAP1,Table S4 : Coloc with GWAS and eQTL,
CLUAP1,Table S4 : Coloc with GWAS and eQTL,
CLUAP1,Table S4 : Coloc with GWAS and eQTL,
TRAP1,Table S4 : Coloc with GWAS and eQTL,
NLRC3,Table S4 : Coloc with GWAS and eQTL,
CLUAP1,Table S4 : Coloc with GWAS and eQTL,
TRAP1,Table S4 : Coloc with GWAS and eQTL,
NLRC3,Table S4 : Coloc with GWAS and eQTL,
NLRC3,Table S4 : Coloc with GWAS and eQTL,
CLUAP1,Table S4 : Coloc with GWAS and eQTL,
NLRC3,Table S4 : Coloc with GWAS and eQTL,
CLUAP1,Table S4 : Coloc with GWAS and eQTL,
CLUAP1,Table S4 : Coloc with GWAS and eQTL,
TRAP1,Table S4 : Coloc with GWAS and eQTL,
CLUAP1,Table S4 : Coloc with GWAS and eQTL,
CLUAP1,Table S4 : Coloc with GWAS and eQTL,
NLRC3,Table S4 : Coloc with GWAS and eQTL,
CLUAP1,Table S4 : Coloc with GWAS and eQTL,
CLUAP1,Table S4 : Coloc with GWAS and eQTL,
HSD17B2,Table S4 : Coloc with GWAS and eQTL,
GCSH,Table S4 : Coloc with GWAS and eQTL,
PLCG2,Table S4 : Coloc with GWAS and eQTL,
7SK,Table S4 : Coloc with GWAS and eQTL,
RASD1,Table S4 : Coloc with GWAS and eQTL,
RAI1,Table S4 : Coloc with GWAS and eQTL,
LRRC48,Table S4 : Coloc with GWAS and eQTL,
TOP3A,Table S4 : Coloc with GWAS and eQTL,
TOM1L2,Table S4 : Coloc with GWAS and eQTL,
TOM1L2,Table S4 : Coloc with GWAS and eQTL,
TOM1L2,Table S4 : Coloc with GWAS and eQTL,
AC122129.1,Table S4 : Coloc with GWAS and eQTL,
TOM1L2,Table S4 : Coloc with GWAS and eQTL,
SMCR5,Table S4 : Coloc with GWAS and eQTL,
SMCR5,Table S4 : Coloc with GWAS and eQTL,
AC122129.1,Table S4 : Coloc with GWAS and eQTL,
TOM1L2,Table S4 : Coloc with GWAS and eQTL,
AC122129.1,Table S4 : Coloc with GWAS and eQTL,
ALKBH5,Table S4 : Coloc with GWAS and eQTL,
TOM1L2,Table S4 : Coloc with GWAS and eQTL,
MYO15A,Table S4 : Coloc with GWAS and eQTL,
TOM1L2,Table S4 : Coloc with GWAS and eQTL,
LRRC48,Table S4 : Coloc with GWAS and eQTL,
LASP1,Table S4 : Coloc with GWAS and eQTL,
SRCIN1,Table S4 : Coloc with GWAS and eQTL,
ACACA,Table S4 : Coloc with GWAS and eQTL,
DUSP14,Table S4 : Coloc with GWAS and eQTL,
TBC1D3,Table S4 : Coloc with GWAS and eQTL,
SNORA21,Table S4 : Coloc with GWAS and eQTL,
RP11-115K3.1,Table S4 : Coloc with GWAS and eQTL,
AC124789.1,Table S4 : Coloc with GWAS and eQTL,
HMSD,Table S4 : Coloc with GWAS and eQTL,
BCL2,Table S4 : Coloc with GWAS and eQTL,
MAP2K7,Table S4 : Coloc with GWAS and eQTL,
CD209,Table S4 : Coloc with GWAS and eQTL,
MCOLN1,Table S4 : Coloc with GWAS and eQTL,
ADAMTS10,Table S4 : Coloc with GWAS and eQTL,
ANGPTL4,Table S4 : Coloc with GWAS and eQTL,
CD320,Table S4 : Coloc with GWAS and eQTL,
TRAPPC5,Table S4 : Coloc with GWAS and eQTL,
KANK3,Table S4 : Coloc with GWAS and eQTL,
CTD-2325M2.1,Table S4 : Coloc with GWAS and eQTL,
RAB11B-AS1,Table S4 : Coloc with GWAS and eQTL,
CTD-3020H12.4,Table S4 : Coloc with GWAS and eQTL,
LRRC8E,Table S4 : Coloc with GWAS and eQTL,
CTD-3193O13.8,Table S4 : Coloc with GWAS and eQTL,
LRRC8E,Table S4 : Coloc with GWAS and eQTL,
CTD-3193O13.9,Table S4 : Coloc with GWAS and eQTL,
EVI5L,Table S4 : Coloc with GWAS and eQTL,
MARK4,Table S4 : Coloc with GWAS and eQTL,
GIPR,Table S4 : Coloc with GWAS and eQTL,
BCL3,Table S4 : Coloc with GWAS and eQTL,
CLASRP,Table S4 : Coloc with GWAS and eQTL,
ERCC2,Table S4 : Coloc with GWAS and eQTL,
EXOC3L2,Table S4 : Coloc with GWAS and eQTL,
ZNF227,Table S4 : Coloc with GWAS and eQTL,
FOXA3,Table S4 : Coloc with GWAS and eQTL,
SIX5,Table S4 : Coloc with GWAS and eQTL,
IGSF23,Table S4 : Coloc with GWAS and eQTL,
AC006126.3,Table S4 : Coloc with GWAS and eQTL,
CTB-179K24.3,Table S4 : Coloc with GWAS and eQTL,
AC074212.6,Table S4 : Coloc with GWAS and eQTL,
VWA5B1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-3
MACF1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-4
MAST2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-5
FAF1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-6
PATJ,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-7
PGM1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-8
ST7L,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-9
PTGFRN,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-10
NOTCH2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-11
CHD1L,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-12
SEC16B,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-13
TSEN15,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-14
ZNF281,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-15
DSTYK-MDM4,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-16
SRGAP2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-17
PROX1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-18
LYPLAL1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-19
ABCB10-NUP133,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-20
TMEM18,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-21
FAM49A,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-22
DTNB,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-23
GCKR,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-24
THADA,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-25
SIX3-SIX2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-26
BNIPL,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-27
BCL11A,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-28
CEP68,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-29
LOC541471,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-30
GLI2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-31
CYTIP,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-32
RBSM1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-33
KCNH7,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-34
GRB14,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-35
GALNT3,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-36
SCHLAP1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-37
IKZF2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-38
IRS1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-39
ATG16L1-DGKD,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-40
PPARG,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-41
UBE2E2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-42
RBM6,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-43
RFT1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-44
CACNA2D3,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-45
PXK,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-46
PSMD6-ADAMTS9,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-47
ZBTB20,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-48
ADCY5,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-49
SLC12A8,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-50
TSC22D2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-51
MBNL1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-52
LEKR1-CCNL1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-53
SLC2A2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-54
CCDC39-FXR1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-55
IGF2BP2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-56
ST6GAL1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-57
BCL6-LPP,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-58
TFRC,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-59
CTBP1-PCGF3-MAEA,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-60
WFS1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-61
LCORL,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-62
GNPDA2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-63
MOB1B,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-64
SCD5,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-65
NKX6-1-CDS1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-66
SMARCAD1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-67
PPP3CA,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-68
SLC9B1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-69
TET2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-70
TMEM154,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-71
PDGFC,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-72
ACSL1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-73
ANKH,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-74
MRPS30,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-75
ITGA1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-76
ARL15,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-77
ANKRD55,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-78
PIK3R1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-79
HMGCR-POC5,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-80
ZBED3,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-81
DMGDH,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-82
RASA1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-83
SLCO6A1-PAM,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-84
CEP120,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-85
PHFI5,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-86
EBF1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-87
FGFR4-NSD1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-88
SSR1-RREB1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-89
JARID2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-90
CDKAL1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-91
MHC region,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-92
ZFAND3-KCNK16-GLP1R,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-93
LRFN2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-94
VEGFA,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-95
TFAP2B,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-96
BEND3,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-97
NUS1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-98
CENPW-SOGA3,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-99
MED23-ENPP3,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-100
SLC35D3,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-101
REPS1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-102
HIVEP2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-103
RGS17,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-104
SLC22A3,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-105
QKI,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-106
FOXK1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-107
ETV1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-108
DGKB,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-109
LOC646588-NFE2L3,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-110
JAZF1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-111
CRHR2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-112
GCK ,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-113
GRB10,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-114
ZNF713,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-115
AUTS2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-116
STEAP1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-117
FBXL13-RELN-RASA4,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-118
GCC1-PAX4-LEP,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-119
KLF14,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-120
BRAF,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-121
AOC1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-122
MNX1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-123
MSRA-XKR6,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-124
LONRF1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-125
LPL,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-126
PURG,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-127
KCNU1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-128
ANK1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-129
PENK,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-130
GDAP1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-131
TP53INP1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-132
TRPS1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-133
SLC30A8,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-134
PVT1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-135
BOP1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-136
DMRT2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-137
GLIS3,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-138
HAUS6,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-139
CDKN2A-CDKN2B,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-140
LINGO2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-141
UBAP2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-142
TLE4,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-143
TLE1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-144
ZNF169,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-145
PTCH1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-146
STRBP,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-147
ABO,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-148
GPSM1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-149
CDC123-CAMK1D,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-150
MYO3A,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-151
JMJD1C,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-152
VPS26A-NEUROG3,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-153
ZNF503-LRMDA,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-154
ZMIZ1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-155
GRID1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-156
PTEN,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-157
HHEX-IDE,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-158
ARHGAP19-SLIT1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-159
BBIP1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-160
TCF7L2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-161
WDR11,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-162
PLEKHA1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-163
INS-IGF2-KCNQ1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-164
TRIM66,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-165
PDE3B,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-166
KCNJ11-ABCC8,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-167
BDNF,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-168
MPPED2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-169
QSER1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-170
PDHX,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-171
HSD17B12,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-172
CRY2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-173
CELF1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-174
FOLH1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-175
MAP3K11,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-176
TPCN2-CCND1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-177
CENTD2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-178
C11orf30,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-179
MTNR1B,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-180
FXYD6-FXYD2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-181
ETS1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-182
CCND2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-183
CDKN1B,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-184
PDE3A,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-185
LDHB-KCNJ8,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-186
ITPR2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-187
KLHDC5,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-188
FAM60A,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-189
PKP2-SYT10,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-190
FAIM2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-191
HMGA2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-192
TSPAN8,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-193
RMST,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-194
WSCD2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-195
SH2B3-ALDH2-BRAP,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-196
PTPN11-HECTD4,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-197
KSR2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-198
HNF1A,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-199
MPHOSPH9-ZNF664,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-200
FBRSL1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-201
SGCG,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-202
RNF6,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-203
KL ,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-204
DLEU1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-205
OLFM4,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-206
SPRY2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-207
MIR17HG,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-208
AKAP6,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-209
CLEC14A,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-210
PSMA3,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-211
LRRC74A,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-212
NRXN3,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-213
FOXN3,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-214
SMEK1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-215
DLK1-MEG3,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-216
TRAF3,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-217
RASGRP1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-218
INFAM2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-219
LTK,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-220
PPIP5K1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-221
MYO5C,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-222
TCF12,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-223
C2CD4A-C2CD4B,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-224
USP3,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-225
MAP2K5,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-226
PTPN9-SIN3A,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-227
HMG20A,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-228
AP3S2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-229
PRC1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-230
RGMA,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-231
ITFG3,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-232
CLUAP1-SLX4,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-233
GP2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-234
FAM57B,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-235
FTO,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-236
NFAT5,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-237
ZFHX3,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-238
BCAR1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-239
CMIP,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-240
ZFPM1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-241
SPG7,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-242
ZZEF1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-243
SLC16A11-SLC16A13,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-244
RAI1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-245
NF1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-246
HNF1B,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-247
MLX,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-248
GIP-TTLL6,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-249
ACE,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-250
BPTF-PITPNC1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-251
CYTH1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-252
LAMA1,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-253
TCF4,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-254
GRP-MC4R,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-255
BCL2A,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-256
CDH7,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-257
ZNF236,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-258
UHRF1-PTPRS,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-259
MAP2K7,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-260
FARSA-ZNF799,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-261
CILP2-TM6SF2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-262
ZNF257,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-263
PEPD,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-264
TOMM40-APOE-GIPR,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-265
ZC3H4,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-266
CFAP61,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-267
FOXA2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-268
RALY,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-269
HNF4A,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-270
EYA2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-271
CEBPB,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-272
TSHZ2,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-273
GNAS,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-274
MTMR3-ZNRF3,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-275
YWHAH,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-276
EP300,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-277
PNPLA3,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-278
PIM3,"Supplementary Table 5. Loci attaining genome-wide significant evidence (p<5x10-8) of association with T2D in multi-ancestry meta-regression (MR-MEGA) of up to 180,834 cases and 1,159,055 controls (effective sample size 492,191).	",https://doi.org/10.1038/s41588-022-01058-279
